nach oben

Zeitschrift für Pneumologie

Erschienen in:

12.10.2018 | Herzinsuffizienz | CME

Lungenbeteiligung bei Herzkrankheiten

verfasst von: Prof. Dr. med. F. J. Meyer, S. Andreas, M. Held, H. Leuchte, H. Worth

Erschienen in: Zeitschrift für Pneumologie | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Lungenbeteiligung bei Herzkrankheiten ist nicht immer eine direkte Schädigung, sondern oftmals eine Folge komplexer kardiorespiratorischer Interaktionen. Anhand 5 ausgewählter Situationen – Lungenfunktion und Ventilation im Schlaf bei chronischer Linksherzinsuffizienz, alveoläre Hämorrhagie unter Antikoagulation, infektiöse Rechtsherzendokarditis, Auswirkungen herzchirurgischer Eingriffe auf pulmonale Funktionen sowie Belastungsreaktion und Atemmuskelfunktion bei idiopathischer pulmonal arterieller Hypertonie – werden die diagnostischen und therapeutischen Herausforderungen dargestellt.

Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agusti A (2016) Chronic obstructive pulmonary disease and cardiac diseases. An urgent need for integrated care. Am J Respir Crit Care Med 194(11):1319–1336CrossRef

Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 391(10120):572–580CrossRef

Chen YGH, Xu D, Xu X, Wang H, Hu X, Lu Z, Kwak D, Xu Y, Gunther R, Huo Y, Weir EK (2012) Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease. Hypertension 59:9

Hawkins NM, Virani S, Ceconi C (2013) Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J 34(36):2795–2803CrossRef

Andreas S, Morguet AJ, Werner GS, Kreuzer H (1996) Ventilatory response to exercise and to carbon dioxide in patients with heart failure. Eur Heart J 17(5):750–755CrossRef

Chua TP, Coats AJ (1995) The lungs in chronic heart failure. Eur Heart J 16(7):882–887CrossRef

Clark AL, Poole-Wilson PA, Coats AJ (1996) Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 28(5):1092–1102CrossRef

Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P et al (2008) The ventilatory classification system effectively predicts hospitalization in patients with heart failure. J Cardiopulm Rehabil Prev 28(3):195–198CrossRef

Apostolo ALP, Palange P, Agalbato C, Molle R, Popovic D (2015) Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure. Int J Cardiol 189:7CrossRef

10.

Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, Kubler W et al (2001) Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 103(17):2153–2158CrossRef

11.

Filusch A, Ewert R, Altesellmeier M, Zugck C, Hetzer R, Borst MM et al (2011) Respiratory muscle dysfunction in congestive heart failure—the role of pulmonary hypertension. Int J Cardiol 150(2):182–185CrossRef

12.

Bauer R, Dehnert C, Schoene P, Filusch A, Bartsch P, Borst MM et al (2007) Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med 101(11):2366–2369CrossRef

13.

Haarmann H, Folle J, Nguyen XP, Herrmann P, Heusser K, Hasenfuss G et al (2016) Sympathetic activation is associated with exercise limitation in COPD. COPD 13(5):589–594CrossRef

14.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 37(27):2129–2200 (Developed with the special contribution of the Heart Failure Association (HFA) of the ESC)CrossRef

15.

Hohlfeld JM, Vogel-Claussen J, Biller H, Berliner D, Berschneider K, Tillmann HC et al (2018) Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med 6(5):368–378CrossRef

16.

Eulenburg C, Wegscheider K, Woehrle H, Angermann C, d’Ortho MP, Erdmann E et al (2016) Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. Lancet Respir Med 4(11):873–881CrossRef

17.

Kip MS, Schönfelder T, Bleß H‑H (2015) Weißbuch Schlaganfallprävention bei Vorhofflimmern. Thieme, Stuttgart

18.

Nitta K, Imamura H, Akihiro Yashio A et al (2016) Diffuse alveolar hemorrhage associated with Edoxaban Therapy. Case Rep Crit Care. https://doi.org/10.1155/2016/7938062 CrossRefPubMedPubMedCentral

19.

Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS et al (2013) Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose. Am J Kidney Dis 62(3):591–594CrossRef

20.

Wijnen PA, Linssen CF, Haenen GR, Bekers O, Drent M (2010) Variant VKORC1 and CYP2C9 alleles in patients with diffuse alveolar hemorrhage caused by oral anticoagulants. Mol Diagn Ther 14(1):23–30CrossRef

21.

Greening AP, Hughes JM (1981) Serial estimations of carbon monoxide diffusing capacity in intrapulmonary haemorrhage. Clin Sci 60(5):507–512CrossRef

22.

Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr., Tleyjeh IM, Rybak MJ et al (2015) Infective Endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132(15):1435–1486CrossRef

23.

Habib G, Lancellotti P, Iung B (2016) 2015 ESC Guidelines on the management of infective endocarditis: a big step forward for an old disease. Heart 102(13):992–994CrossRef

24.

Frantz S, Buerke M, Horstkotte D et al (2016) Kommentar zu den 2015 Leitlinien der Europäischen Gesellschaft für Kardiologie zur Infektiösen Endokarditis. Kardiologe 10:7. https://doi.org/10.1007/s12181-016-0058-4 CrossRef

25.

Szelkowski LA, Puri NK, Singh R, Massimiano PS (2015) Current trends in preoperative, intraoperative, and postoperative care of the adult cardiac surgery patient. Curr Probl Surg 52(1):531–569CrossRef

26.

Urell C, Westerdahl E, Hedenstrom H, Janson C, Emtner M (2012) Lung function before and two days after open-heart surgery. Crit Care Res Pract 2012:291628PubMedPubMedCentral

27.

Westerdahl E, Lindmark B, Bryngelsson I, Tenling A (2003) Pulmonary function 4 months after coronary artery bypass graft surgery. Respir Med 97(4):317–322CrossRef

28.

Urell C, Emtner M, Hedenstrom H, Westerdahl E (2016) Respiratory muscle strength is not decreased in patients undergoing cardiac surgery. J Cardiothorac Surg 11:41CrossRef

29.

Taggart DP (2000) Respiratory dysfunction after cardiac surgery: effects of avoiding cardiopulmonary bypass and the use of bilateral internal mammary arteries. Eur J Cardiothorac Surg 18(1):31–37CrossRef

30.

Altarabsheh SE, Deo SV, Dunlay SM, Erwin PJ, Obeidat YM, Navale S et al (2017) Meta-analysis of usefulness of concomitant mitral valve repair or replacement for moderate ischemic mitral regurgitation with coronary artery bypass grafting. Am J Cardiol 119(5):734–741CrossRef

31.

Weissman C (2004) Pulmonary complications after cardiac surgery. Semin Cardiothorac Vasc Anesth 8(3):185–211CrossRef

32.

Allou N, Bronchard R, Guglielminotti J, Dilly MP, Provenchere S, Lucet JC et al (2014) Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score. Crit Care Med 42(5):1150–1156CrossRef

33.

He S, Chen B, Li W, Yan J, Chen L, Wang X et al (2014) Ventilator-associated pneumonia after cardiac surgery: a meta-analysis and systematic review. J Thorac Cardiovasc Surg 148(6):3148–3155 (e1–5)CrossRef

34.

Stephens RS, Shah AS, Whitman GJ (2013) Lung injury and acute respiratory distress syndrome after cardiac surgery. Ann Thorac Surg 95(3):1122–1129CrossRef

35.

Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL (2006) Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 296(15):1851–1857CrossRef

36.

Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2015) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 46(4):903–975 (The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT))CrossRef

37.

Meyer FJ, Ewert R, Hoeper MM, Olschewski H, Behr J, Winkler J et al (2002) Peripheral airway obstruction in primary pulmonary hypertension. Thorax 57(6):473–476CrossRef

38.

Laveneziana P, Humbert M, Godinas L, Joureau B, Malrin R, Straus C et al (2015) Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J 45(5):1495–1498CrossRef

39.

Naeije R (2014) Lung mechanics and exertional dyspnea in pulmonary arterial hypertension. Respiration 88(1):16–17CrossRef

40.

Laveneziana P, Garcia G, Joureau B, Nicolas-Jilwan F, Brahimi T, Laviolette L et al (2013) Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J 41(3):578–587CrossRef

41.

Droste AS, Rohde D, Voelkers M, Filusch A, Bruckner T, Borst MM et al (2009) Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension. Respir Res 10:129CrossRef

42.

Meyer FJ, Lossnitzer D, Kristen AV, Schoene AM, Kubler W, Katus HA et al (2005) Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J 25(1):125–130CrossRef

43.

Kabitz HJ, Schwoerer A, Bremer HC, Sonntag F, Walterspacher S, Walker D et al (2008) Impairment of respiratory muscle function in pulmonary hypertension. Clin Sci 114(2):165–171CrossRef

44.

Sun XG, Hansen JE, Oudiz RJ, Wasserman K (2001) Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104(4):429–435CrossRef

45.

Dumitrescu D, Sitbon O, Weatherald J, Howard LS (2017) Exertional dyspnoea in pulmonary arterial hypertension. Eur Respir Rev. https://doi.org/10.1183/16000617.0039-2017 CrossRefPubMed

46.

Richter MJ, Tiede H, Morty RE, Voswinckel R, Seeger W, Schulz R et al (2014) The prognostic significance of inspiratory capacity in pulmonary arterial hypertension. Respiration 88(1):24–30CrossRef

47.

Richter MJ, Voswinckel R, Tiede H, Schulz R, Tanislav C, Feustel A et al (2012) Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension. Respir Med 106(2):308–313CrossRef

48.

Meyer FJ, Borst MM, Buschmann HC, Ewert R, Friedmann-Bette B, Ochmann U et al (2013) Exercise testing in respiratory medicine. Pneumologie 67(1):16–34CrossRef

49.

Yan S, Kaminski D, Sliwinski P (1997) Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156(1):55–59CrossRef

50.

Criee CP, Baur X, Berdel D, Bosch D, Gappa M, Haidl P et al (2015) Standardization of spirometry: 2015 update. Published by German Atemwegsliga, German Respiratory Society and German Society of Occupational and Environmental Medicine. Pneumologie 69(3):147–164CrossRef

51.

Naeije R (2005) Breathing more with weaker respiratory muscles in pulmonary arterial hypertension. Eur Respir J 25(1):6–8CrossRef

Titel: Lungenbeteiligung bei Herzkrankheiten
verfasst von: Prof. Dr. med. F. J. Meyer
S. Andreas
M. Held
H. Leuchte
H. Worth
Publikationsdatum: 12.10.2018
Verlag: Springer Medizin
Schlagwörter: Herzinsuffizienz
Endokarditis
Herzchirurgie
Herzchirurgie
Pulmonale Hypertonie
Pulmonale Hypertonie
Pulmonale Hypertonie
Pulmonale Hypertonie
Erschienen in: Zeitschrift für Pneumologie / Ausgabe 6/2018
Print ISSN: 2731-7404
Elektronische ISSN: 2731-7412
DOI: https://doi.org/10.1007/s10405-018-0211-9

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Die „Rheumalunge“ im CT – Radiologische Manifestationen der rheumatoiden Arthritis

Schnelles Handeln gefragt: pulmonale Hypertonie bei rheumatischen Erkrankungen

Pneumologie meets Rheumatologie

Mitteilungen des Berufsverbands der Pneumologen in Baden-Württemberg

So toxisch sind NSAR, MTX & Biologika für die Lunge

Was steckte wirklich hinter dem "akuten Atemwegsinfekt"?